Erythropoietin Increases Neuronal NDPKA Expression, and NDPKA Up-Regulation as well as Exogenous Application Protects Cortical Neurons from In Vitro Ischemia-Related Insults
Autor: | Jonathan Teoh, Joanne Chieng, Sherif Boulos, Bruno P. Meloni, Neville W. Knuckey |
---|---|
Rok vydání: | 2014 |
Předmět: |
Cell Survival
Excitotoxicity Biology medicine.disease_cause Neuroprotection Brain Ischemia Rats Sprague-Dawley Brain ischemia Cellular and Molecular Neuroscience Downregulation and upregulation Cell surface receptor medicine Animals Humans education Erythropoietin Cells Cultured Cerebral Cortex Neurons education.field_of_study Cell Biology General Medicine medicine.disease Rats Up-Regulation Cell biology HEK293 Cells Neuroprotective Agents Gene Expression Regulation Nucleoside-Diphosphate Kinase Neuroscience Intracellular Nucleoside diphosphate kinase A medicine.drug |
Zdroj: | Cellular and Molecular Neurobiology. 34:379-392 |
ISSN: | 1573-6830 0272-4340 |
DOI: | 10.1007/s10571-013-0023-8 |
Popis: | Using proteomics, we identified nucleoside diphosphate kinase A (NDPKA; also known as NME/NM23 nucleoside diphosphate kinase 1: NME1) to be up-regulated in primary cortical neuronal cultures by erythropoietin (EPO) preconditioning. To investigate a neuroprotective role of NDPKA in neurons, we used a RNAi construct to knock-down and an adenoviral vector to overexpress the protein in cortical neuronal cultures prior to exposure to three ischemia-related injury models; excitotoxicity (L-glutamic acid), oxidative stress (hydrogen peroxide), and in vitro ischemia (oxygen-glucose deprivation). NDPKA down-regulation had no effect on neuronal viability following injury. By contrast, NDPKA up-regulation increased neuronal survival in all three-injury models. Similarly, treatment with NDPKA recombinant protein increased neuronal survival, but only against in vitro ischemia and excitotoxicity. These findings indicate that the NDPKA protein may confer a neuroprotective advantage following injury. Furthermore, as exogenous NDPKA protein was neuroprotective, it suggests that a cell surface receptor may be activated by NDPKA leading to a protective cell-signaling response. Taken together both NDPKAs intracellular and extracellular neuroprotective actions suggest that the protein is a legitimate therapeutic target for the design of drugs to limit neuronal death following stroke and other forms of brain injury. |
Databáze: | OpenAIRE |
Externí odkaz: |